| Abstract: | The investigation deals with constitutional and insurance law problems of gene tests on completion of life and health insurance contracts. There are predominate reasons for the admissibility of a fundamental prohibition of predictive gene tests as a requirement of the completion of an insurance contract. Exceptions from the prohibition are only thinkable in special cases. Gene tests that were already performed should be allowed to be used by the insurer (only) if the insurer offers an expectancy insurance to the person affected. Furthermore the person must be informed about possible insurance related and legal risks before commencement of the test by the physician. |
